Bioceres Crop Solutions (NASDAQ:BIOX) Announces Quarterly Earnings Results

Bioceres Crop Solutions (NASDAQ:BIOXGet Free Report) announced its earnings results on Thursday. The company reported $0.09 earnings per share for the quarter, beating analysts’ consensus estimates of $0.07 by $0.02, MarketWatch Earnings reports. The firm had revenue of $140.30 million for the quarter, compared to analyst estimates of $108.97 million. Bioceres Crop Solutions had a net margin of 4.36% and a return on equity of 5.97%. During the same quarter in the previous year, the firm posted ($0.14) EPS.

Bioceres Crop Solutions Trading Up 6.7 %

NASDAQ:BIOX opened at $13.57 on Friday. Bioceres Crop Solutions has a one year low of $9.76 and a one year high of $14.20. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82. The company’s 50-day simple moving average is $13.34 and its 200 day simple moving average is $12.05. The firm has a market capitalization of $852.20 million, a P/E ratio of 42.41 and a beta of 0.54.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. UBS Group AG lifted its stake in shares of Bioceres Crop Solutions by 4.7% in the first quarter. UBS Group AG now owns 37,468 shares of the company’s stock worth $435,000 after buying an additional 1,676 shares in the last quarter. Stifel Financial Corp bought a new position in shares of Bioceres Crop Solutions in the first quarter worth approximately $361,000. Geode Capital Management LLC lifted its stake in shares of Bioceres Crop Solutions by 11.0% in the first quarter. Geode Capital Management LLC now owns 29,815 shares of the company’s stock worth $346,000 after buying an additional 2,947 shares in the last quarter. Millennium Management LLC purchased a new position in shares of Bioceres Crop Solutions during the fourth quarter valued at approximately $323,000. Finally, Sei Investments Co. purchased a new position in shares of Bioceres Crop Solutions during the second quarter valued at approximately $221,000. Institutional investors own 13.35% of the company’s stock.

Analyst Ratings Changes

Separately, Roth Mkm boosted their price objective on shares of Bioceres Crop Solutions from $20.00 to $21.00 and gave the stock a “buy” rating in a research note on Friday.

View Our Latest Stock Analysis on Bioceres Crop Solutions

About Bioceres Crop Solutions

(Get Free Report)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.

Recommended Stories

Earnings History for Bioceres Crop Solutions (NASDAQ:BIOX)

Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.